# Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain

> **NCT04737278** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mitosynergy LLC** · enrollment: 56 (actual)

## Conditions studied

- Neuralgia
- Myalgia

## Interventions

- **DRUG:** Cunermuspir
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04737278
- **Lead sponsor:** Mitosynergy LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-28
- **Primary completion:** 2014-05-28
- **Final completion:** 2014-09-29
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04737278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04737278, "Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04737278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*